One Stop Systems (OSS) Can OSS Make Up for the First Quarter Miss? More
Cumulus Media (CMLS) It’s Expected To Get A Little Noisy.
More
Dyadic International (DYAI) Putting Recent Developments Into Perspective. More
Tegna, Inc. (TGNA) Eye on 2020. More
Trovagene Inc. (TROV) Data Rich Year Ahead. More
INITIATION – Electrocore (ECOR) Small Piece of Migraine Market Could be a Big Deal. More
Could the commercial success of cell cycle regulators lead to broadening
developmental pipeline and the importance of CDKs (cyclin-dependent kinases). Cell proliferation is a tightly regulated process by the cell cycle machinery in normal tissues… More
Who will sit on the oil throne? On April 12th, Chevron Corp agreed to buy Anadarko Petroleum Corp for $50 billion including debt. The acquisition would make Chevron as big as Exxon and Shell and double down its position in the Permian Oil Basin…
More
IPO Podcast Episode 2: Drug Disruption. Brant Pinvidic (host of the iTunes top-trending Hollywood podcast “Why I’m Not…”) probes into the positive aspects of being “disruptive” in healthcare. Changing what is viewed as the norm – disrupting the status quo -can result in very positive change… Like Uber and Airbnb. Here Brant looks for disruption in healthcare; ways to reduce the costs associated with prescription drugs. He interviews the CEO of Dyadic International who believes his company has the answer. You be the judge. More
